More and more people are being diagnosed with pancreatic cancer. This disease is insidious, often only making itself known in ...
Genelux Corporation’s GNLX share price has dipped by 12.21%, which has investors questioning if this is right time to buy.
With the newly completed OT-101 and IL-2 Phase 1 trial, Oncotelic is poised to begin further combination trials to determine the added efficacy of OT-101, IL-2, and CKIs in solid tumors such as lung ...
The AACR poster presentation will provide an update on the data in AML patients most recently presented at the American ...
Black Americans face higher rates and lower survival. Research explores biological, social factors, and disparities.
Dr. Waltzman's panel, titled "Ensuring Effective and Efficient Trials Through Clinical Operations” will be Monday, April 7 th from 4:05PM - 4:35PM ET.
Cancer advocates, researchers, clinicians and patients are speaking out in a new STAT News article published this week about ...
Yale scientists have discovered a promising way to trigger immune responses against certain tumors, using a lupus-related antibody that can slip, undetected, into "cold" tumors and flip on an immune ...
Pancreatic cancer is notoriously hard to treat and often diagnosed at such a late stage that patients have one of the worst ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback